Particle.news
Download on the App Store
6 ARTICLES
·
yesterday

FDA Limits COVID-19 Vaccine Approvals to Seniors and High-Risk Groups

The new policy narrows eligibility for routine vaccine approval, potentially reducing access and insurance coverage for healthier individuals.

Image
Image
Image
Image

Overview

  • The FDA announced it will limit routine COVID-19 vaccine approvals to those aged 65 and older and individuals with risk factors for severe illness.
  • Manufacturers are being urged to conduct new clinical trials to demonstrate vaccine efficacy for healthier populations.
  • The CDC's advisory panel is set to meet in June to provide updated recommendations for the fall COVID-19 vaccination campaign.
  • Experts warn the policy could reduce vaccine access for the general public and limit insurance coverage for healthy adults and children.
  • COVID-19 continues to pose significant health risks, with 30,000 to 50,000 adult deaths since October and high hospitalization rates among seniors and children under 2.